hydroxyl radical has been researched along with entacapone in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (entacapone) | Trials (entacapone) | Recent Studies (post-2010) (entacapone) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 503 | 112 | 173 |
| Protein | Taxonomy | hydroxyl radical (IC50) | entacapone (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 6.8 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 0.223 | |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 1.275 | |
| Adenosine receptor A2a | Homo sapiens (human) | 2.32 | |
| Alpha-ketoglutarate-dependent dioxygenase FTO | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerlach, M; Kuhn, W; Lehnfeld, R; Riederer, P; Sontag, KH; Waldmeier, P; Xiao, AY | 1 |
1 other study(ies) available for hydroxyl radical and entacapone
| Article | Year |
|---|---|
The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Hydroxyl Radical; Levodopa; Male; Microdialysis; Nitriles; Nitrophenols; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Wistar; Tolcapone | 2001 |